In-silico trials with human modelling and simulation for guiding optimal stratification of atrial fibrillation patients to catheter ablation and pharmacological therapy
<p>Atrial fibrillation (AF) is the most prevalent sustained arrhythmia, affecting over 43 million people worldwide and one in 45 people in the UK. The modest efficacy of currently available therapies adds to the nature of the problem. Antiarrhythmic medication and catheter ablation are the two...
第一著者: | Dasí i Martinez, A |
---|---|
その他の著者: | Bueno Orovio, A |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2023
|
主題: |
類似資料
-
In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
著者:: Albert Dasí, 等
出版事項: (2022-09-01) -
Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
著者:: Jaemin Shim, 等
出版事項: (2017-10-01) -
Commentary: Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
著者:: Axel Loewe, 等
出版事項: (2017-12-01) -
Catheter Ablation for Atrial Fibrillation
著者:: Andre J. Gauri, 等
出版事項: (2003-10-01) -
Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
著者:: Sergio Conti, 等
出版事項: (2023-09-01)